Overview
Shiro Fujita practices practicing medicine in Kobe, Japan.
Mr. Fujita is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Squamous Cell Lung Carcinoma, and EGFR Positive Lung Cancer.
He is actively involved in clinical research, co-authoring 90 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Shiro Fujita
Is Shiro Fujita a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Shiro Fujita is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Shiro Fujita participate in research or clinical trials?
Yes. Shiro Fujita has published 90 articles and abstracts on conditions like Lung Cancer. You can view a list of Shiro Fujita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMr. Fujita isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Fujita isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- EGFR Positive Lung CancerMr. Fujita isAdvanced. Learn about EGFR Positive Lung Cancer.
- Squamous Cell Lung CarcinomaMr. Fujita isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Acute Interstitial PneumoniaMr. Fujita isExperienced. Learn about Acute Interstitial Pneumonia.
- Breast CancerMr. Fujita isExperienced. Learn about Breast Cancer.
- Esophageal CancerMr. Fujita isExperienced. Learn about Esophageal Cancer.
- Febrile NeutropeniaMr. Fujita isExperienced. Learn about Febrile Neutropenia.
- HemangioendotheliomaMr. Fujita isExperienced. Learn about Hemangioendothelioma.
- Hepatic Venoocclusive Disease with Immunodeficiency
- Interstitial Lung DiseaseMr. Fujita isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaMr. Fujita isExperienced. Learn about Lung Adenocarcinoma.
- Lymphofollicular HyperplasiaMr. Fujita isExperienced. Learn about Lymphofollicular Hyperplasia.
- Oral CancerMr. Fujita isExperienced. Learn about Oral Cancer.
- Papillary Thyroid CancerMr. Fujita isExperienced. Learn about Papillary Thyroid Cancer.
- ParonychiaMr. Fujita isExperienced. Learn about Paronychia.